Results 91 to 100 of about 18,251 (231)

Potentiometric determination of alendronate in pharmaceutical formulations

open access: yes, 2004
A simple, precise, fast and low-cost potentiometric method for alendronate determination in pharmaceutical formulations has been proposed. Alendronate present in tablets at the known concentration was potentiometrically titrated in an aqueous solution ...
Pezza, Leonardo   +2 more
core   +3 more sources

Alendronate therapy in men with primary hyperparathyroidism.

open access: yes, 2009
OBJECTIVE: To determine the skeletal effects of alendronate therapy in men with primary hyperparathyroidism (PHPT) in comparison with those in postmenopausal women. METHODS: There essentially are no published data on the effects of bisphosphonate therapy
Syed, ZA   +5 more
core   +1 more source

Evaluation of an aminobisphosphonate (alendronate) in the management of periodontal osseous defects

open access: yesJournal of Indian Society of Periodontology, 2010
Background and Objectives: Alendronate, an aminobisphosphonate, is capable of inhibiting periodontitis associated osteoclastic activity and hence is effective in protecting the alveolar bone in periodontitis.
Veena H, Prasad Deepak
doaj  

Risk of long-term infection-related death in clinical osteoporotic vertebral fractures: A hospital-based analysis.

open access: yesPLoS ONE, 2017
BackgroundOsteoporotic vertebral fractures adversely impact quality of life and also increase the risk of infection and mortality. Alendronate treatment increases bone mass and reduces the risk of fractures in patients with osteoporosis by suppressing ...
Ying-Chou Chen, Wei-Che Lin
doaj   +1 more source

The comparison of effects of alendronate and raloxifene treatment in postmenauposal women with osteoporosis - Original Investigation

open access: yes, 2005
This study was performed to compare and to research the effects of raloxifene and alendronate for the treatment of postmenopausal osteoporosis women. Thirty two women with postmenopausal osteoporosis (raloxifene group:16 patients, alendronate group: 16 ...
Ayhan Erkek   +4 more
core  

The Comparison of Effects of Alendronate and Raloxifene Treatment in Postmenopausal Women with Osteoporosis - Original Investigation

open access: yes, 2006
This study was performed to assess and compare the effects of raloxifene and alendronate for the treatment of postmenopausal osteoporosis. Thirty-two women with postmenopausal osteoporosis (raloxifene group:16 patients, alendronate group: 16 patients ...
Ayhan Erkek   +4 more
core  

Upconversion nanoparticles coated with Alendronate and PEG-conjugated Alendronate

open access: yes, 2018
Upconverting nanoparticles (UCNPs) have gained traction as diagnostic and imaging probes for biological applications due to their many unique optical properties.
Najib, Hifza
core   +1 more source

Alendronate-coated long-circulating liposomes containing 99mtechnetium-ceftizoxime used to identify osteomyelitis

open access: yes, 2015
Diego dos Santos Ferreira,1 Fernanda Alves Boratto,1 Valbert Nascimento Cardoso,2 Rogéria Serakides,3 Simone Odília Fernandes,2 Lucas Antônio Miranda Ferreira,1 Mônica Cristina Oliveira1 1Department of Pharmaceutical Products ...
Cardoso VN   +6 more
core  

Bilateral Femoral Insufficiency Fractures Likely Related to Long-Term Alendronate Therapy

open access: yesJournal of Osteoporosis, 2011
Osteoporosis-related fractures are a major public health problem and one in two women and one in four men are affected with osteoporosis-related fractures.
Ravindra Gudena   +2 more
doaj   +1 more source

Baseline and follow-up data for non–alendronate and alendronate patients.

open access: yes, 2013
Abbreviations: BMD, bone mineral density; BUN, blood urea nitrogen; C-Ca, serum corrected calcium; Cr, blood creatinine; CMV, cytomegalovirus; DM, diabetes mellitus; FN, femoral neck; H, hip; HBV, hepatitis B virus; HCV, hepatitis C virus; LS, lumbar ...
Ping-Chin Lai (297993)   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy